Impact of Angiotensin-converting enzyme inhibitors administration prior to acute ischemic stroke onset on in-hospital mortality

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 15, Issue 3, 2010, Pages 274-281

  Hassan, Yahaya ^a   Aziz, Noorizan Abd ^a   Al Jabi, Samah W ^a,b   Looi, Irene ^c   Zyoud, Sa'Ed H ^b,d  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b AN NAJAH NATIONAL UNIVERSITY   (Palestine)

^c HOSPITAL PULAU PINANG   (Malaysia)

^d SCHOOL OF PHYSICS   (Malaysia)

Author keywords

acute ischemic stroke; angiotensin converting enzyme inhibitors; in hospital mortality

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE BRAIN DISEASE; ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART FAILURE; HOSPITAL DISCHARGE; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COHORT STUDIES; DIABETES COMPLICATIONS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PATIENT DISCHARGE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77956864216     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248410373751     Document Type: Article

References (39)

1. American Heart Association. Heart Disease and Stroke Statistics-2006 Update. Dallas, TX: American Heart Association ; 2006.
2. World Health Organization. Cardiovascular diseases. www.who.int/ mediacentre/factsheets/fs317/en/print.html. Accessed March 6, 2010.
3. Numminen H., Kaste M., Aho K., Waltimo O., Kotila M. Decreased severity of brain infarct can in part explain the decreasing case fatality rate of stroke. Stroke. 2000 ; 31 (3). 651-655.
4. Centers for Disease Control and Prevention. Decline in deaths from heart disease and stroke-United States, 1900-1999. MMWR Morb Mortal Wkly Rep. 1999 ; 48 (30). 649-656.
5. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000 ; 342 (3). 145-153. (Pubitemid 30051645)
6. Selim M., Savitz S., Linfante I., Caplan L., Schlaug G. Effect of pre-stroke use of ACE inhibitors on ischemic stroke severity. BMC Neurol. 2004 ; 5 (1). 10-14.
7. Fuentes B., Fernández-Dominguez J., Ortega-Casarrubios MA, SanJosé B., Martinez Sánchez P., Diez-Tejedor E. Treatment with angiotensin receptor blockers before stroke could exert a favourable effect in acute cerebral infarction. J Hypertens. 2010 ; 28 (3). 575-581.
8. Francis GS ACE inhibition in cardiovascular disease. N Engl J Med. 2001 ; 342 (3). 201-202.
9. Basri H., Azman Ali R. Predictors of in-hospital mortality after an acute ischaemic stroke. Neurol J Southeast Asia. 2003 ; 8 (1). 5-8.
10. Lisabeth LD, Diez Roux AV, Escobar JD, Smith MA, Morgenstern LB Neighborhood environment and risk of ischemic stroke: the brain attack surveillance in Corpus Christi (BASIC) Project. Am J Epidemiol. 2007 ; 165 (3). 279-287.
11. Al-Wabil A., Smith MA, Moye LA, Burgin WS, Morgenstern LB Improving efficiency of stroke research: the Brain Attack Surveillance in Corpus Christi Study. J Clin Epidemiol. 2003 ; 56 (4). 351-357.
12. Morgenstern LB, Smith MA, Lisabeth LD, et al. Excess stroke in Mexican Americans compared with non-Hispanic whites: the Brain Attack Surveillance in Corpus Christi Project. Am J Epidemiol. 2004 ; 160 (4). 376-383.
13. Warlow C., Sudlow C., Dennis M., Wardlaw J., Sandercock P. Stroke. Lancet. 2003 ; 362 (9391). 2121-2124.
14. Bamford J., Sandercock P., Dennis M., Burn J., Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991 ; 337 (8756). 1521-1526.
15. Hacke W., Kaste M., Fieschi C., et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).. JAMA. 1995 ; 274 (13). 1017-1025.
16. Hajat C., Dundas R., Stewart JA, et al. Cerebrovascular risk factors and stroke subtypes: differences between ethnic groups. Stroke. 2001 ; 32 (1). 37-42. (Pubitemid 32063820)
17. Pinto A., Tuttolomondo A., Di Raimondo D., Fernandez P., Licata G. Cerebrovascular risk factors and clinical classification of strokes. Semin Vasc Med. 2004 ; 4 (3). 287-303.
18. Waring WS, Jamie H., Leggett GE Delayed onset of acute renal failure after significant paracetamol overdose: a case series. Hum Exp Toxicol. 2010 ; 29 (1). 63-68.
19. Kernan WN, Viscoli CM, Brass LM, et al. The stroke prognosis instrument II (SPI-II): a clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke. Stroke. 2000 ; 31 (2). 456-462.
20. Asawavichienjinda T., Boongird P. Cerebrovascular disease in North East Thailand. Neurol J Southeast Asia. 1998 ; 3 (1). 27-33.
21. Di Sciacca R., Tuttolomondo A., Di Raimondo D., La Placa S., Pinto A., Licata G. Cardiovascular drugs pre-treatment related prognosis in patients with acute ischemic stroke. Nutr Metab Cardiovasc Dis. 2008 ; 18 (suppl 1). S45.
22. Chitravas N., Dewey HM, Nicol MB, Harding DL, Pearce DC, Thrift AG Is restrike use of angiotensin-converting enzyme inhibitors associated with better outcome ? Neurology. 2007 ; 68 (20). 1687-1693.
23. Frankel MR, Morgenstern LB, Kwiatkowski T., et al. Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial. Neurology. 2000 ; 55 (7). 952-959.
24. Lewington S., Clarke R., Qizilbash N., Peto R., Collins R. ;. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002 ; 360 (9349). 1903-1913.
25. Kranzhofer R., Schmidt J., Pfeiffer CA, Hagl S., Libby P., Kubler W. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999 ; 19 (7). 1623-1629. (Pubitemid 29323820)
26. Daugherty A., Manning WM, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest. 2000 ; 105 (11). 1605-1612.
27. Yoshimoto T., Fukai N., Sato R., et al. Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation in vascular smooth muscle cells. Endocrinology. 2004 ; 145 (7). 3331-3337.
28. Jamrozik K., Broadhurst RJ, Forbes S., Hankey GJ, Anderson CS Predictors of death and vascular events in the elderly: the Perth Community Stroke Study. Stroke. 2000 ; 31 (4). 863-868.
29. SzczepaÅ.,ska-Szerej A., Wojczal J., Belniak E., KrasiÅ.,ska-Czerlunczakiewicz H., Stelmasiak Z. Does diabetes mellitus affect the course and prognosis of ischemic stroke? Neurol Neurochir Pol. 2003 ; 37 (2). 327-337.
30. Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke-2002 update: Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002 ; 106 (3). 388-391.
31. American Diabetes Association. ADA clinical practice recommendations. Diabetes Care. 2004 ; 27 (suppl 1). S1 - S143.
32. Koren-Morag N., Goldbourt U., Tanne D. Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. Neurology. 2006 ; 67 (2). 224-228.
33. Seliger SL, Gillen DL, Tirschwell D., Wasse H., Kestenbaum BR, Stehman-Breen CO Risk factors for incident stroke among patients with end-stage renal disease. J Am Soc Nephrol. 2003 ; 14 (10). 2623-2631. (Pubitemid 37169349)
34. Sweileh WM Predictors of in-hospital mortality after acute stroke: impact of renal dysfunction. Int J Clin Pharmacol Ther. 2008 ; 46 (12). 637-643.
35. Sweileh WM, Sawalha AF, Al-Aqad SM, Zyoud SH, Al-Jabi SW Predictors of in-hospital mortality after acute stroke: impact of gender. Int J Clin Exp Med. 2009 ; 2 (1). 41-47.
36. Wannamethee SG, Shaper AG, Perry IJ Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke. Stroke. 1997 ; 28 (3). 557-563.
37. Appelros P., Nydevik I., Sieger A., Terent A. Predictors of severe stroke: Influence of pre-existing dementia and cardiac disorders. Stroke. 2002 ; 33 (10). 2357-2362.
38. Zuliani G., Cherubini A., Ranzini M., Ruggiero C., Atti AR, Fellin R. Risk factors for short-term mortality in older subjects with acute ischemic stroke. Gerontology. 2006 ; 52 (4). 231-236. (Pubitemid 44114442)
39. Oppenhaeimer SM, Hachinski VC The cardiac consequences of stroke. Neurol Clin. 1992 ; 10 (1). 167-176.